Recurrent joint pain, temperamental digestion, inflammatory fatigue: what if the common thread ran through the curcumin in turmeric? The webinar by Benoît Fillon, founder of the Optime brand, clarified what the active ingredient really involves, how to think about its bioavailability, and the situations in which to use it, or avoid it, in your practice.
Why these approaches enrich your practice
Positioning curcumin as a non-drug adjuvant fits within a logic of preventive medicine and personalisation. By refining the assessment (inflammatory terrain, comorbidities, current treatments) and the choice of formulation (piperine, microencapsulation, phospholipid complexes), the practitioner strengthens perceived effectiveness while keeping the prescription safe. These practical suggestions reflect Simplycure’s commitment to bringing theory and practice closer together for a tangible impact on patients.
Turmeric, curcuminoids, curcumin: setting the right benchmarks
The rhizome of Curcuma longa contains several curcuminoids, of which curcumin is the most studied fraction for its anti-inflammatory and antioxidant effects. Distinguishing the culinary spice (turmeric powder) from a standardised extract guides the clinical expectation: the food acts mainly on the microbiota and digestion, whereas extracts target more specific inflammatory pathways.
Practical applications: favour everyday culinary use for mild functional digestive disorders; reserve the standardised extract for structured anti-inflammatory goals, after reviewing contraindications.
Pharmacokinetics: understanding the low bioavailability
The pharmacokinetics of curcumin are marked by low aqueous solubility, first-pass metabolism and rapid glucuronidation. Clinical consequence: the effects depend as much on the formulation as on the raw dose. Avoid empirical escalation; favour the form best suited to the patient’s profile.
Practical applications: advise taking it with a meal containing quality fats; plan a structured reassessment (pain, morning stiffness, digestive comfort) to objectively track the response.
Optimising absorption: piperine, microencapsulation and cofactors
Several strategies exist for improving bioavailability: combining with piperine, microencapsulation, lipid or phospholipid complexes. Each has advantages (e.g. increased absorption) and points needing caution (e.g. potential interactions with enzyme substrates).
Micro-protocols without dosage: choose a single optimisation technology at a time; start with a single daily dose taken with a fatty meal; document co-occurring symptoms (sleep, transit, physical activity) to refine personalisation.
Clinical targets: when to consider it, when to hold back
Osteoarthritis pain or tendinopathies: as an adjuvant to baseline measures (activity, weight loss, physiotherapy), curcumin fits within a broader anti-inflammatory strategy. Common mistake: neglecting lifestyle while relying solely on the extract.
Digestive comfort and bloating: the culinary spice and certain gentle forms can support digestion. Warning sign: acute abdominal pain, weight loss, rectal bleeding: refer for further investigation.
Inflammatory metabolic terrain: the value is assessed case by case, in synergy with nutrition, activity and sleep. To avoid: substituting for validated treatments.
Precautions, contraindications, interactions
At-risk populations: pregnancy, breastfeeding, a history of gallstones or biliary tract obstruction, active ulcer, haemostasis disorders, anticoagulants or antiplatelet agents. The presence of piperine can potentiate drug interactions (as a precautionary principle).
Actionable advice: systematically review medication (prescriptions, OTC, phytotherapy); start with the simplest form (without absorption multipliers) in patients on multiple medications; stop if abnormal digestive or bleeding symptoms occur and reconsider the indication.
Comparison table: choosing the approach according to the profile
Patient profileClinical goalPriority approachPoints of cautionKnee/hip osteoarthritisReduce pain and stiffnessStandardised extract plus rehabilitation plus activityAssess concurrent analgesic/anti-inflammatory prescriptionsChronic tendinopathy in athletesControl low-grade inflammationOptimised form during painful phasesMonitor digestive tolerance, training loadFunctional digestive disordersSupport digestion, microbiotaDaily culinary use, gentle formRule out digestive warning signsPatient on anticoagulantsPrevent interactionsPrefer non-interfering alternativesAvoid curcumin and piperinePregnancy / early post-partumPrioritise safetyLifestyle and dietary advice, no extractNo established safety data
5 habits to build in from tomorrow
- Document the precise indication (osteoarthritis pain, digestive comfort, inflammatory terrain) and the associated assessment criterion.
- Choose a single optimisation technology (e.g. microencapsulation or piperine) and reassess tolerance within 2 to 3 clinical weeks.
- Systematically review medication (prescription plus OTC) to screen for the risk of interaction.
- Start by taking it with a fatty meal, avoid rapid escalation and favour continuity.
- Update therapeutic education: the extract replaces neither exercise, nor nutrition, nor sleep.
Essential points for your practice
Curcumin can earn its place as a structured adjuvant when the indication is clear, the formulation suited to the patient and safety reassessed. In keeping with the Simplycure approach, these solutions help strengthen clinical impact day to day by providing benchmarks that are simple, reproducible and personalisable.
FAQs
Culinary turmeric or curcumin extract: how do you choose?
Culinary turmeric mainly targets the microbiota and digestion; curcumin extract is considered for a targeted anti-inflammatory goal after reviewing the terrain and the risks.
Is piperine always desirable?
No. While it improves absorption, it can potentiate drug interactions; caution is needed in patients on multiple medications or taking anticoagulants.
Which situations require avoiding curcumin?
Pregnancy/breastfeeding, gallstones or biliary obstruction, active ulcer, haemostasis disorders, anticoagulant or antiplatelet treatments.
How can you assess effectiveness without overmedicalising?
Define 1 to 2 clinical criteria in advance (pain, stiffness, digestive comfort) and schedule a structured reassessment; if there is no benefit, reconsider the indication.
What role do Optime and the speaker play in these recommendations?
The webinar by Benoît Fillon (the Optime brand) clarified terminology, pharmacokinetics and optimisation strategies, for safe, personalised use. This approach reflects the Simplycure mission: supporting every practitioner in building concrete, workable clinical expertise.
.png)
